期刊文献+

UPLC-MS/MS法测定人血浆中双氯芬酸钠的浓度 被引量:5

Determination of diclofenac's concentration in plasma by UPLC-MS/MS
下载PDF
导出
摘要 目的建立测定人血浆中双氯芬酸钠浓度的超高效液相色谱-串联质谱(LC-MS/MS)检测方法。方法采用蛋白沉淀法处理血浆样品。色谱柱为Waters C18(50 mm×2.1 mm,1.7μm),流动相为乙腈-体积分数为0.06%的甲酸溶液(体积比为40∶60),流速为0.7 m L·min-1,正离子模式多反应监测(MRM)扫描分析,离子通道分别为m/z 296.03→249.98(双氯芬酸钠),m/z 358.10→138.92(吲哚美辛,内标物)。结果血浆中双氯芬酸钠线性为10~3 000μg·L-1(r=0.998 0),定量下限为10μg·L-1,提取回收率在95.1%~101.3%,日内、日间精密度RSD均小于10%。结论该方法可用于双氯芬酸钠的药物动力学研究。 Objective To establish a UPLC-M S/M S method for the determination of diclofenac in human plasma.Methods The plasma procedure involved a single-step protein precipitation by acetonitrile,then a chromatography was proceeded on a Waters ACQUITY UPLC BEH C18column(50 mm × 2.1 mm,1.7 μm) using a mobile phase consisted of acetonitrile-0.06%(φ) formic acid(V ∶ V = 40∶ 60) at a flow rate of 0.7 m L·min-1.The protonated ions of analytes were detected in positive ionization in multiple reaction monitoring mode(M RM).The mass transition pairs of m/z 296.03 →249.98 and 358.10 →138.92 were used to detect diclofenac and indomethacin.Results The calibration curve was linear over a concentration range of 10 to 3 000 μg·L-1(r = 0.998 0) and the low limit of quantitation was 10 μg·L-1.The extraction recovery rates were ranged from 95.1% to 101.3%,with-day RSD and between-day RSD were all less than 10%.Conclusions The method is simple and quick,with high specificity and sensitivity,and suitable for the research of diclofenac pharmacokinetics.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2014年第12期979-983,共5页 Journal of Shenyang Pharmaceutical University
关键词 双氯芬酸钠 超高效液相色谱 串联质谱 药物动力学 血浆 diclofenac UPLC tandem mass spectrometry pharmacokinetics plasma
  • 相关文献

参考文献4

二级参考文献23

  • 1张守尧,邹恒琴,张忠义,彭万力,刘丽卿.高效液相色谱法测定血清中双氯芬酸浓度及在人体的药代动力学[J].药学学报,1994,29(3):228-231. 被引量:10
  • 2李科 赵飞朗 袁倚盛 等.RP-HPLC测定人血浆中双氯芬酸钠浓度 [J].药物分析杂志,1995,15(5):17-17. 被引量:1
  • 3[1]Brogden RN, Heel RC, Pakes GE. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain varying origin[J]. Drug, 1980;20(1):24 被引量:1
  • 4[2]Terhaag B, Hoffmann A, Barkworth M, Vens-Cappell B. Bioavailability of a new effervescent tablet of diclofenac [ J ]. Int J Clin Pharmacol Ther, 2000;38(11) :546 - 51 被引量:1
  • 5[5]Walter K, von Nieciecki A. Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets [ J ]. Arzneimittelforschung, 2001;51(8) :643 - 50 被引量:1
  • 6[6]Zmeili S, Hasan M, Najib N, Sallam E, Deleq S, Shubair M.Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, voltaren vs inflaban:effect of food on inflaban bioavailibility[J]. Int J Clin Pharmacol Ther, 1996;34(12) :564- 70 被引量:1
  • 7[7]Raz I, Hussein Z, Samara E, Ben-David J. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects[J]. Int J Clin Pharmacol Ther Toxicol, 1988;26(5) :246 - 8 被引量:1
  • 8YILMAZ B.GC-MS Determination of diclofenac in human plasma[J].Chromatographia.2010,71(5-6):549-551. 被引量:1
  • 9CHOI MH,CHOI Y K,CHUNG BC.Rapid and sensitive analysis of diclofenac in human plasma by GC/SIM/MS[J].Anal Lett.1999,32(11):2245-2253. 被引量:1
  • 10EMAMI J,GHASSAMI N,TALARI R.A rapid and sensitive modified HPLC method for determination of diclofenac in human phis-in a and its application in pharmacokinetic studies[J].Daru-Journal of Faculty of Pharmacy,2007,15(3):132-138. 被引量:1

共引文献23

同被引文献51

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部